Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Argus Health
Citi
US Army
US Department of Justice
Fuji
Medtronic
Moodys

Generated: April 25, 2018

DrugPatentWatch Database Preview

TRIATEX Drug Profile

« Back to Dashboard

When do Triatex patents expire, and what generic alternatives are available?

Triatex is a drug marketed by Ivax Pharms and is included in three NDAs.

The generic ingredient in TRIATEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-seven suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for TRIATEX
Drug patent expirations by year for TRIATEX
Medical Subject Heading (MeSH) Categories for TRIATEX

US Patents and Regulatory Information for TRIATEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms TRIATEX triamcinolone acetonide CREAM;TOPICAL 087430-001 Nov 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Pharms TRIATEX triamcinolone acetonide CREAM;TOPICAL 087429-001 Nov 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Pharms TRIATEX triamcinolone acetonide CREAM;TOPICAL 087428-001 Nov 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Cantor Fitzgerald
Chubb
Queensland Health
UBS
US Department of Justice
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.